Why It Matters
Summit Anesthesia has hired a lobbying firm to navigate insurance issues, marking the organization's entry into federal advocacy. The move comes as the anesthesia sector faces significant pressure from major insurers and federal regulators, with reimbursement cuts and policy changes threatening the industry's economics.
Broader Context
The anesthesia industry is contending with mounting financial pressures. United Healthcare implemented a 15% reduction in reimbursement for Certified Registered Nurse Anesthetist (CRNA) services billed with the QZ modifier, effective October 1, 2025. The Centers for Medicare and Medicaid Services is imposing a negative 2.5% efficiency adjustment that cuts relative value units for non-time-based services. Anthem previously halted an anesthesia time-cap plan after criticism from anesthesiologists and government officials.
Between The Lines
Congressional attention to anesthesia access has been steady. Multiple House members have met with anesthesia groups about expanding rural access and strengthening physician-led care models. Rep. Jan Schakowsky (D-IL-9) and Rep. Dave Joyce (R-OH-14) reintroduced a bipartisan resolution recognizing National CRNA Week. A search for anesthesia in congressional hearing statements returned 12 exact matches, though Summit Anesthesia itself was not named in any witness or speaker records.
The Bottom Line
The lobbyists listed on the filing include Andrew Woods and Eric Berger.
Access the Legis1 platform for comprehensive political news, data, and insights.
Spot something wrong? Report an issue with this article